Intrinsic Value of S&P & Nasdaq Contact Us

Corbus Pharmaceuticals Holdings, Inc. CRBP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.33
+333.3%

Stock Statistics — CRBP

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a market capitalization of $125.36M and trades at $10.00. The 52-week range is 4.64-20.56.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.7, Earnings Per Share (EPS) of $-5.90.

The stock has a beta of 2.79, operates in the Healthcare sector.

Trading Data
Current Price$10.00
52-Week Range4.64-20.56
Volume223.95K
Avg Volume (30D)232.32K
Market Cap$125.36M
Beta (1Y)2.79
Company
IPO Date2014-10-27
Employees28
CEOYuval Cohen
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS21833P3010
CUSIP21833P103
Income (Latest Year)
Gross Profit$-233K
EBITDA$-85.08M
Operating Income$-85.31M
Net Income$-78.54M
EPS$-5.90
EPS Diluted$-5.90
Shares Outstanding$13.32M
Balance Sheet (Latest Year)
Total Assets$168.2M
Current Assets$166.95M
Cash & ST Investments$163.94M
Total Liabilities$20.69M
Total Debt$1.63M
Net Debt$-26.86M
Total Equity$147.5M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-1.7
P/B Ratio0.85
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message